Merck prevails in state Fosamax case; United Therapeutics plots N.C. facility expansion;

 @FiercePharma:  Should Big Pharma spin off to goose shares? News |  Follow @FiercePharma

> A jury in state Superior Court in Atlantic City said Fosamax, an osteoporosis medicine made by Merck, did not cause a Pennsylvania woman's jawbone to deteriorate. Article

> United Therapeutics is planning a major expansion of its research-and-manufacturing facility in North Carolina's Research Triangle Park that would allow it to triple its local work force. Report

> KV Pharmaceutical plans to sell nearly 10 million shares at $3.25 each to a group of institutional investors for a total of $32 million. News

> Pfizer has sold more than half of its former Brooklyn, N.Y., complex to a company planning to bring new light-manufacturing and commercial jobs to the long-shuttered site. Item

> Watson Pharmaceuticals' quarterly net income dropped due to legal and acquisition charges, but the generic drugmaker's profit excluding items was in line with analyst expectations. Article

> The Société générale de financement du Québec, a holding company for the provincial government, will proceeed with a $14.7 million equity reinvestment in Axcan Pharma to help fund its $587 million acquisition of Eurand Pharmaceuticals. Report

> Specialty pharmaceutical company Warner Chilcott forecast its 2011 profit range at $3.45 to $3.55 per share, in line with analyst estimates. Story

> Patients using aspirin for heart-attack prevention don't usually need proton pump inhibitors to reduce the risk of bleeding, a new study shows. News

Biotech News

@FierceBiotech: GSK plots new approach to working with academia. Story | Follow @FierceBiotech

@JohnCFierce: BIO: Overall success rates from Phase I to FDA approval is nearly 9%. Item | Follow @JohnCFierce 

> Boston scores R&D coup with Merck KGaA's new hub. Item

> Philogen cancels IPO after Bayer pulls out of cancer deal. News

> Lilly to raise $750M to share R&D costs. Report

> Dealmakers: 2011 should see surge of new M&A pacts. Item 

> Sinclair, IS Pharma in merger talks. News 

Biotech Research News

> Scientists generate lab-dish human heart model. Article 

> Obama pitches $1B boost to NIH funding. Story 

> Mouse-human study IDs celiac disease triggers. Report

> Prostate cancer genome map spotlights DNA damage. News 

> Charles River posts Q4 loss on preclinical writedown. Story

Manufacturing News

> Crucell wins back WHO with plant power fixes. Story 

> Pfizer inherits Wyeth site clean-up. Item 

> FDA zigs to inspect, zags to funds threat. Report

> CMO taps Capsugel for early-phase supply edge. News 

> India considers drug-inspector job requirements. Article 

> Pfizer taps DHL for Australia distribution. Story 

And Finally... The non-profit organization that sets quality and safety standards for drugs approved by FDA is aiming to simplify, clarify and standardize the labels that are affixed to those drugs. Report